MedPath

Effects of Satureja Khuzestanica Jamzad on type 2 diabetes

Phase 2
Recruiting
Conditions
Type 2 Diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20190715044214N1
Lead Sponsor
Khoram-Abad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
78
Inclusion Criteria

Age between 20 and 65 years
BMI between 18.5 and 35
Willingness to cooperate
Completing the informed consent form

Exclusion Criteria

Insulin therapy
Pregnancy
Lactation
Allergy to Satureja Khuzestanica
Being on weight loss diet

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FBS. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;TG. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;LDL-c. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;AST. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath